Evidence map›Paper›PMID 34218665›Full record

ArticleCartilage2021

Fatty Acid-Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis.

Paul Schadler, Birgit Lohberger, Bettina Thauerer, Martin Faschingbauer, Werner Kullich, Martin Helmut Stradner, Rusmir Husic, Andreas Leithner, Bibiane Steinecker-Frohnwieser

Open access · bronzeAbstract read
In one paragraph

Article in Cartilage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Paul SchadlerDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.ORCID 0000-0001-9633-1469
Birgit LohbergerDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Bettina ThauererDepartment for Rehabilitation, Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Saalfelden, Austria.ORCID 0000-0001-8357-4082
Martin FaschingbauerDepartment of Orthopaedic Surgery, University Hospital Ulm, Ulm, Germany.
Werner KullichDepartment for Rehabilitation, Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Saalfelden, Austria.
Martin Helmut StradnerDivision of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Rusmir HusicDivision of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Andreas LeithnerDepartment of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria.
Bibiane Steinecker-FrohnwieserDepartment for Rehabilitation, Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Gröbming, Austria.
Medical University of Graz · ATLudwig Boltzmann Institute for Arthritis and Rehabilitation · ATUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is no single blood biomarker for the staging of knee osteoarthritis (KOA). The purpose of this study was to assess the relationship of obesity, serum biomarkers, the hip-knee-ankle angle (HKAA) with sonographic cartilage thickness.

methodsWe conducted a cross-sectional study of

resultsAfter adjusting for age, gender, and HKAA, obese patients had thicker medial femoral cartilage (β = 0.165, DISCUSSION: Our results indicate that BMI has a weak, positive association with cartilage thickness in end-stage KOA patients. FABP4 levels were negatively associated with cartilage thickness. While our study is limited by a small sample size, these results further highlight the role of FABP4 as promising biomarkers of burden of disease in KOA.

Indexed as

Fatty Acid-Binding ProteinsOsteoarthritis, KneeCartilageCross-Sectional StudiesHumansReceptor for Advanced Glycation End ProductsFABP4 protein, humanFatty Acid-Binding ProteinsReceptor for Advanced Glycation End ProductsbiomarkersFABP4kneeobesityultrasound

Identifiers

PMID34218665
PMCPMC8804752
OpenAlexW3177777007

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.